市場調査レポート

商品コード

1221034

臨床試験管理システムの世界市場：標準的な臨床ワークフローへのデジタル技術の統合の発展、医薬品CRO活動の拡大が市場を促進

Growing Integration of Digital Technologies into Standard Clinical Workflows, as well as the Growing Pharmaceutical CRO Activities will propel the Adoption of Clinical Trial Management Systems

出版日: 2022年12月29日 | 発行: Persistence Market Research

| ページ情報: 英文 111 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピーはできません。PDFの印刷もできません。

PDF (Multi User License)

USD 7,600 1,191,376円

レポートPDFを同一企業内の5名様までご利用頂けるライセンスです。PDF内のテキストの編集が可能です。PDFの印刷は5部までとし、そのご利用はPDFのご利用範囲に準拠します。

PDF (Corporate User License)

USD 10,600 1,661,656円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキストの編集が可能です。印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートでは、世界の臨床試験管理システム市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、配信モード別・システムタイプ別・コンポーネント別・エンドユーザー別・地域別の分析、および競合分析などを提供しています。

マクロ経済要因
- 世界のGDP成長の見通し
- 世界のヘルスケアの見通し
予測要因 - 関連性と影響
- 研究開発費の増加
- 製品採用率
- 最近発売/承認された製品
- 規制方針の変更
- 戦略的コラボレーション
市場力学
- 促進要因
- 抑制要因
- 機会分析

第6章 COVID-19危機分析

COVID-19と影響分析
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
- 国別
2022年の市場シナリオ

第7章世界の臨床試験管理システム市場の需要の分析と予測

過去の市場分析
現在および将来の市場予測
- 前年比成長トレンド分析の分析

第8章世界の臨床試験管理システム市場分析と予測：配信モード別

イントロダクション/主な調査結果
過去の市場分析：配信モード別
現在および将来の市場分析と予測：配信モード別
- クラウドベース
- ウェブベース
- オンプレミス
市場の魅力分析：配信モード別

第9章世界の臨床試験管理システム市場分析と予測：システムタイプ別

イントロダクション/主な調査結果
過去の市場分析：システムタイプ別
現在および将来の市場分析と予測：システムタイプ別
- 企業ベース
- サイトベース
市場魅力分析：システムタイプ別

第10章世界の臨床試験管理システム市場分析と予測：コンポーネント別

イントロダクション/主な調査結果
過去の市場分析：コンポーネント別
現在および将来の市場分析と予測：コンポーネント別
- ハードウェア
- サービス
市場魅力分析：コンポーネント別

第11章世界の臨床試験管理システム市場分析と予測：エンドユーザー別

イントロダクション/主な調査結果
過去の市場分析：エンドユーザー別
現在および将来の市場分析と予測：エンドユーザー別
- 医薬品
- 臨床研究機関（CRO）
- 医療提供者
市場魅力分析：エンドユーザー別

第12章世界の臨床試験管理システム市場分析と予測：地域別

イントロダクション
過去の市場分析：地域別
現在および将来の市場分析と予測：地域別
- 北米
- ラテンアメリカ
- 欧州
- 東アジア
- 南アジア
- オセアニア
- 中東・アフリカ
市場魅力度分析：地域別

第13章北米の臨床試験管理システム市場分析と予測

イントロダクション
過去の市場動向分析：市場分類別
現在および将来の市場分析と予測分析：市場分類別
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場魅力分析
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場動向
促進要因と抑制要因 - 影響分析
主要企業 - 強度マッピング
国レベルの分析と予測
- 米国の臨床試験管理システム市場分析
- カナダの臨床試験管理システム市場分析

第14章ラテンアメリカの臨床試験管理システム市場分析と予測

イントロダクション
過去の市場動向分析：市場分類別
現在および将来の市場分析と予測分析：市場分類別
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場魅力分析
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場動向
促進要因と抑制要因 - 影響分析
主要企業 - 強度マッピング
国レベルの分析と予測
- メキシコの臨床試験管理システム市場分析
- ブラジルの臨床試験管理システム市場分析
- アルゼンチンの臨床試験管理システム市場分析

第15章欧州の臨床試験管理システム市場分析と予測

イントロダクション
過去の市場動向分析：市場分類別
現在および将来の市場分析と予測分析：市場分類別
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場魅力分析
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場動向
促進要因と抑制要因 - 影響分析
主要企業 - 強度マッピング
国レベルの分析と予測
- ドイツの臨床試験管理システム市場分析
- イタリアの臨床試験管理システム市場分析
- フランスの臨床試験管理システム市場分析
- 英国の臨床試験管理システム市場分析
- スペインの臨床試験管理システム市場分析
- ベネルクスの臨床試験管理システム市場分析
- ロシアの臨床試験管理システム市場分析

第16章東アジアの臨床試験管理システム市場分析と予測

イントロダクション
過去の市場動向分析：市場分類別
現在および将来の市場分析と予測分析：市場分類別
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場魅力分析
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場動向
促進要因と抑制要因 - 影響分析
主要企業 - 強度マッピング
国レベルの分析と予測
- 中国の臨床試験管理システム市場分析
- 日本の臨床試験管理システム市場分析
- 韓国の臨床試験管理システム市場分析

第17章南アジアの臨床試験管理システム市場分析と予測

イントロダクション
過去の市場動向分析：市場分類別
現在および将来の市場分析と予測分析：市場分類別
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場魅力分析
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場動向
促進要因と抑制要因 - 影響分析
主要企業 - 強度マッピング
国レベルの分析と予測
- インドの臨床試験管理システム市場分析
- インドネシアの臨床試験管理システム市場分析
- マレーシアの臨床試験管理システム市場分析
- タイの臨床試験管理システム市場分析

第18章オセアニアの治験管理システムの市場と予測

イントロダクション
過去の市場動向分析：市場分類別
現在および将来の市場分析と予測分析：市場分類別
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場魅力分析
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場動向
促進要因と抑制要因 - 影響分析
主要企業 - 強度マッピング
国レベルの分析と予測
- オーストラリアの臨床試験管理システム市場分析
- ニュージーランドの臨床試験管理システム市場分析

第19章中東・アフリカの臨床試験管理システム市場分析と予測

イントロダクション
過去の市場動向分析：市場分類別
現在および将来の市場分析と予測分析：市場分類別
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場魅力分析
- 国別
- 配信モード別
- システムタイプ別
- コンポーネント別
- エンドユーザー別
市場動向
促進要因と抑制要因 - 影響分析
主要企業 - 強度マッピング
国レベルの分析と予測
- GCC諸国の臨床試験管理システム市場分析
- トルコの臨床試験管理システム市場分析
- 南アフリカの臨床試験管理システム市場分析
- 北アフリカの臨床試験管理システム市場分析

第20章市場構造分析

市場分析：企業層別
主要企業の市場シェア分析
市場プレゼンス分析

第21章競合分析

競合ダッシュボード
競合の詳細
- Oracle Corporation
- Merge Healthcare Incorporated
- Medidata Solutions Inc.
- PAREXEL International Corporation
- BioClinica
- MedNet Solutions, Inc.
- Bio-Optronics, Inc.
- DSG, Inc.
- eClinForce, Inc.
- Forte Research Systems, Inc.

第22章使用される前提条件と頭字語

第23章調査手法

図表

List of Tables

Table 01: Global Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 02: Global Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 03: Global Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 04: Global Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by End User
Table 05: Global Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Region
Table 06: North America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Country
Table 07: North America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 08: North America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 09: North America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 10: North America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by End User
Table 11: Latin America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Country
Table 12: Latin America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 13: Latin America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 14: Latin America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 15: Latin America Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by End User
Table 16: Europe Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Country
Table 17: Europe Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 18: Europe Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 19: Europe Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 20: Europe Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by End User
Table 21: East Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Country
Table 22: East Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 23: East Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 24: East Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 25: East Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by End User
Table 26: South Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Country
Table 27: South Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 28: South Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 29: South Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 30: South Asia Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by End User
Table 31: Oceania Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Country
Table 32: Oceania Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 33: Oceania Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 34: Oceania Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 35: Oceania Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by End User
Table 36: Middle East & Africa Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Country
Table 37: Middle East & Africa Clinical Trial Management System Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, by Mode of Delivery
Table 38: Middle East & Africa Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by System Type
Table 39: Middle East & Africa Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by Component
Table 40: Middle East & Africa Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, by End User

List of Figures

Figure 01: Global Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 02: Global Clinical Trial Management System Market Forecast & Y-o-Y Growth, 2023-2033
Figure 03: Global Clinical Trial Management System Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
Figure 04: Global Clinical Trial Management System Market Value Share (%) Analysis 2023 and 2033, by Mode of Delivery
Figure 05: Global Clinical Trial Management System Market Y-o-Y Growth (%) Analysis 2022-2033, by Mode of Delivery
Figure 06: Global Clinical Trial Management System Market Attractiveness Analysis 2023-2033, by Mode of Delivery
Figure 07: Global Clinical Trial Management System Market Value Share (%) Analysis 2023 and 2033, by System Type
Figure 08: Global Clinical Trial Management System Market Y-o-Y Growth (%) Analysis 2022-2033, by System Type
Figure 09: Global Clinical Trial Management System Market Attractiveness Analysis 2023-2033, by System Type
Figure 10: Global Clinical Trial Management System Market Value Share (%) Analysis 2023 and 2033, by Component
Figure 11: Global Clinical Trial Management System Market Y-o-Y Growth (%) Analysis 2022-2033, by Component
Figure 12: Global Clinical Trial Management System Market Attractiveness Analysis 2023-2033, by Component
Figure 13: Global Clinical Trial Management System Market Value Share (%) Analysis 2023 and 2033, by End User
Figure 14: Global Clinical Trial Management System Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
Figure 15: Global Clinical Trial Management System Market Attractiveness Analysis 2023-2033, by End User
Figure 16: Global Clinical Trial Management System Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 17: Global Clinical Trial Management System Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 18: Global Clinical Trial Management System Market Attractiveness Analysis 2023-2033, by Region
Figure 19: North America Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 20: North America Clinical Trial Management System Market Value (US$ Mn) Forecast, 2023-2033
Figure 21: North America Clinical Trial Management System Market Value Share, by Mode of Delivery (2023 E)
Figure 22: North America Clinical Trial Management System Market Value Share, by System Type (2023 E)
Figure 23: North America Clinical Trial Management System Market Value Share, by Component (2023 E)
Figure 24: North America Clinical Trial Management System Market Value Share, by End User (2023 E)
Figure 25: North America Clinical Trial Management System Market Value Share, by Country (2023 E)
Figure 26: North America Clinical Trial Management System Market Attractiveness Analysis by Mode of Delivery, 2023-2033
Figure 27: North America Clinical Trial Management System Market Attractiveness Analysis by System Type, 2023-2033
Figure 28: North America Clinical Trial Management System Market Attractiveness Analysis by Component, 2023-2033
Figure 29: North America Clinical Trial Management System Market Attractiveness Analysis by End User, 2023-2033
Figure 30: North America Clinical Trial Management System Market Attractiveness Analysis by Country, 2023-2033
Figure 31: U.S. Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 32: Global Vs. U.S. Growth Comparison, 2022 - 2033
Figure 33: U.S. Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 34: U.S. Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 35: U.S. Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 36: U.S. Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 37: Canada Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 38: Global Vs. Canada. Growth Comparison, 2022 - 2033
Figure 39: Canada Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 40: Canada Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 41: Canada Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 42: Canada Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 43: Latin America Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 44: Latin America Clinical Trial Management System Market Value (US$ Mn) Forecast, 2023-2033
Figure 45: Latin America Clinical Trial Management System Market Value Share, by Mode of Delivery (2023 E)
Figure 46: Latin America Clinical Trial Management System Market Value Share, by System Type (2023 E)
Figure 47: Latin America Clinical Trial Management System Market Value Share, by Component (2023 E)
Figure 48: Latin America Clinical Trial Management System Market Value Share, by End User (2023 E)
Figure 49: Latin America Clinical Trial Management System Market Value Share, by Country (2023 E)
Figure 50: Latin America Clinical Trial Management System Market Attractiveness Analysis by Mode of Delivery, 2023-2033
Figure 51: Latin America Clinical Trial Management System Market Attractiveness Analysis by System Type, 2023-2033
Figure 52: Latin America Clinical Trial Management System Market Attractiveness Analysis by Component, 2023-2033
Figure 53: Latin America Clinical Trial Management System Market Attractiveness Analysis by End User, 2023-2033
Figure 54: Latin America Clinical Trial Management System Market Attractiveness Analysis by Country, 2023-2033
Figure 55: Mexico Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 56: Global Vs Mexico Growth Comparison, 2022 - 2033
Figure 57: Mexico Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 58: Mexico Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 59: Mexico Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 60: Mexico Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 61: Brazil Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 62: Global Vs. Brazil. Growth Comparison, 2022 - 2033
Figure 63: Brazil Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 64: Brazil Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 65: Brazil Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 66: Brazil Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 67: Argentina Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 68: Global Vs Argentina Growth Comparison, 2022 - 2033
Figure 69: Argentina Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 70: Argentina Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 71: Argentina Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 72: Argentina Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 73: Europe Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 74: Europe Clinical Trial Management System Market Value (US$ Mn) Forecast, 2023-2033
Figure 75: Europe Clinical Trial Management System Market Value Share, by Mode of Delivery (2023 E)
Figure 76: Europe Clinical Trial Management System Market Value Share, by System Type (2023 E)
Figure 77: Europe Clinical Trial Management System Market Value Share, by Component (2023 E)
Figure 78: Europe Clinical Trial Management System Market Value Share, by End User (2023 E)
Figure 79: Europe Clinical Trial Management System Market Value Share, by Country (2023 E)
Figure 80: Europe Clinical Trial Management System Market Attractiveness Analysis by Mode of Delivery, 2023-2033
Figure 81: Europe Clinical Trial Management System Market Attractiveness Analysis by System Type, 2023-2033
Figure 82: Europe Clinical Trial Management System Market Attractiveness Analysis by Component, 2023-2033
Figure 83: Europe Clinical Trial Management System Market Attractiveness Analysis by End User, 2023-2033
Figure 84: Europe Clinical Trial Management System Market Attractiveness Analysis by Country, 2023-2033
Figure 85: UK Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 86: Global Vs. UK Growth Comparison, 2022 - 2033
Figure 87: UK Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 88: UK Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 89: UK Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 90: UK Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 91: Germany Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 92: Global Vs. Germany Growth Comparison, 2022 - 2033
Figure 93: Germany Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 94: Germany Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 95: Germany Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 96: Germany Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 97: Italy Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 98: Global Vs. Italy Growth Comparison, 2022 - 2033
Figure 99: Italy Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 100: Italy Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 101: Italy Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 102: Italy Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 103: France Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 104: Global Vs France Growth Comparison, 2022 - 2033
Figure 105: France Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 106: France Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 107: France Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 108: France Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 109: Spain Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 110: Global Vs Spain Growth Comparison, 2022 - 2033
Figure 111: Spain Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 112: Spain Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 113: Spain Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 114: Spain Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 115: Russia Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 116: Global Vs Russia Growth Comparison, 2022 - 2033
Figure 117: Russia Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 118: Russia Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 119: Russia Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 120: Russia Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 121: BENELUX Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 122: Global Vs BENELUX Growth Comparison, 2022 - 2033
Figure 123: BENELUX Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 124: BENELUX Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 125: BENELUX Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 126: BENELUX Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 127: East Asia Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 128: East Asia Clinical Trial Management System Market Value (US$ Mn) Forecast, 2023-2033
Figure 129: East Asia Clinical Trial Management System Market Value Share, by Mode of Delivery (2023 E)
Figure 130: East Asia Clinical Trial Management System Market Value Share, by System Type (2023 E)
Figure 131: East Asia Clinical Trial Management System Market Value Share, by Component (2023 E)
Figure 132: East Asia Clinical Trial Management System Market Value Share, by End User (2023 E)
Figure 133: East Asia Clinical Trial Management System Market Value Share, by Country (2023 E)
Figure 134: East Asia Clinical Trial Management System Market Attractiveness Analysis by Mode of Delivery, 2023-2033
Figure 135: East Asia Clinical Trial Management System Market Attractiveness Analysis by System Type, 2023-2033
Figure 136: East Asia Clinical Trial Management System Market Attractiveness Analysis by Component, 2023-2033
Figure 137: East Asia Clinical Trial Management System Market Attractiveness Analysis by End User, 2023-2033
Figure 138: East Asia Clinical Trial Management System Market Attractiveness Analysis by Country, 2023-2033
Figure 139: China Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 140: Global Vs. China Growth Comparison, 2022 - 2033
Figure 141: China Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 142: China Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 143: China Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 144: China Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 145: Japan Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 146: Global Vs. Japan Growth Comparison, 2022 - 2033
Figure 147: Japan Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 148: Japan Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 149: Japan Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 150: Japan Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 151: South Korea Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 152: Global Vs South Korea Growth Comparison, 2022 - 2033
Figure 153: South Korea Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 154: South Korea Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 155: South Korea Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 156: South Korea Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 157: South Asia Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 158: South Asia Clinical Trial Management System Market Value (US$ Mn) Forecast, 2023-2033
Figure 159: South Asia Clinical Trial Management System Market Value Share, by Mode of Delivery (2023 E)
Figure 160: South Asia Clinical Trial Management System Market Value Share, by System Type (2023 E)
Figure 161: South Asia Clinical Trial Management System Market Value Share, by Component (2023 E)
Figure 162: South Asia Clinical Trial Management System Market Value Share, by End User (2023 E)
Figure 163: South Asia Clinical Trial Management System Market Value Share, by Country (2023 E)
Figure 164: South Asia Clinical Trial Management System Market Attractiveness Analysis by Mode of Delivery, 2023-2033
Figure 165: South Asia Clinical Trial Management System Market Attractiveness Analysis by System Type, 2023-2033
Figure 166: South Asia Clinical Trial Management System Market Attractiveness Analysis by Component, 2023-2033
Figure 167: South Asia Clinical Trial Management System Market Attractiveness Analysis by End User, 2023-2033
Figure 168: South Asia Clinical Trial Management System Market Attractiveness Analysis by Country, 2023-2033
Figure 169: India Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 170: Global Vs. India Growth Comparison, 2022 - 2033
Figure 171: India Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 172: India Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 173: India Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 174: India Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 175: Indonesia Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 176: Global Vs. Indonesia Growth Comparison, 2022 - 2033
Figure 177: Indonesia Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 178: Indonesia Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 179: Indonesia Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 180: Indonesia Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 181: Malaysia Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 182: Global Vs. Malaysia Growth Comparison, 2022 - 2033
Figure 183: Malaysia Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 184: Malaysia Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 185: Malaysia Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 186: Malaysia Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 187: Thailand Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 188: Global Vs. Thailand Growth Comparison, 2022 - 2033
Figure 189: Thailand Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 190: Thailand Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 191: Thailand Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 192: Thailand Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 193: Oceania Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 194: Oceania Clinical Trial Management System Market Value (US$ Mn) Forecast, 2023-2033
Figure 195: Oceania Clinical Trial Management System Market Value Share, by Mode of Delivery (2023 E)
Figure 196: Oceania Clinical Trial Management System Market Value Share, by System Type (2023 E)
Figure 197: Oceania Clinical Trial Management System Market Value Share, by Component (2023 E)
Figure 198: Oceania Clinical Trial Management System Market Value Share, by End User (2023 E)
Figure 199: Oceania Clinical Trial Management System Market Value Share, by Country (2023 E)
Figure 200: Oceania Clinical Trial Management System Market Attractiveness Analysis by Mode of Delivery, 2023-2033
Figure 201: Oceania Clinical Trial Management System Market Attractiveness Analysis by System Type, 2023-2033
Figure 202: Oceania Clinical Trial Management System Market Attractiveness Analysis by Component, 2023-2033
Figure 203: Oceania Clinical Trial Management System Market Attractiveness Analysis by End User, 2023-2033
Figure 204: Oceania Clinical Trial Management System Market Attractiveness Analysis by Country, 2023-2033
Figure 205: Australia Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 206: Global Vs. Australia Growth Comparison, 2022 - 2033
Figure 207: Australia Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 208: Australia Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 209: Australia Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 210: Australia Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 211: New Zealand Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 212: Global Vs New Zealand Growth Comparison, 2022 - 2033
Figure 213: New Zealand Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 214: New Zealand Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 215: New Zealand Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 216: New Zealand Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 217: Middle East & Africa Clinical Trial Management System Market Value (US$ Mn) Analysis, 2016-2022
Figure 218: Middle East & Africa Clinical Trial Management System Market Value (US$ Mn) Forecast, 2023-2033
Figure 219: Middle East & Africa Clinical Trial Management System Market Value Share, by Mode of Delivery (2023 E)
Figure 220: Middle East & Africa Clinical Trial Management System Market Value Share, by System Type (2023 E)
Figure 221: Middle East & Africa Clinical Trial Management System Market Value Share, by Component (2023 E)
Figure 222: Middle East & Africa Clinical Trial Management System Market Value Share, by End User (2023 E)
Figure 223: Middle East & Africa Clinical Trial Management System Market Value Share, by Country (2023 E)
Figure 224: Middle East & Africa Clinical Trial Management System Market Attractiveness Analysis by Mode of Delivery, 2023-2033
Figure 225: Middle East & Africa Clinical Trial Management System Market Attractiveness Analysis by System Type, 2023-2033
Figure 226: Middle East & Africa Clinical Trial Management System Market Attractiveness Analysis by Component, 2023-2033
Figure 227: Middle East & Africa Clinical Trial Management System Market Attractiveness Analysis by End User, 2023-2033
Figure 228: Middle East & Africa Clinical Trial Management System Market Attractiveness Analysis by Country, 2023-2033
Figure 229: GCC Countries Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 230: Global Vs GCC Countries Growth Comparison, 2022 - 2033
Figure 231: GCC Countries Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 232: GCC Countries Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 233: GCC Countries Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 234: GCC Countries Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 235: Turkey Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 236: Global Vs. Turkey Growth Comparison, 2022 - 2033
Figure 237: Turkey Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 238: Turkey Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 239: Turkey Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 240: Turkey Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 241: South Africa Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 242: Global Vs. South Africa Growth Comparison, 2022 - 2033
Figure 243: South Africa Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 244: South Africa Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 245: South Africa Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 246: South Africa Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033
Figure 247: North Africa Clinical Trial Management System Market Value Proportion Analysis, 2022
Figure 248: Global Vs North Africa Growth Comparison, 2022 - 2033
Figure 249: North Africa Clinical Trial Management System Market Share Analysis (%) by Mode of Delivery, 2022 & 2033
Figure 250: North Africa Clinical Trial Management System Market Share Analysis (%) by System Type, 2022 & 2033
Figure 251: North Africa Clinical Trial Management System Market Share Analysis (%) by Component, 2022 & 2033
Figure 252: North Africa Clinical Trial Management System Market Share Analysis (%) by End User, 2022 & 2033

Product Code: PMRREP3017

Clinical Trial Management System Market: Scope of the Report

The latest publication by Persistence Market Research on the global clinical trial management system market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for clinical trial management systems and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the clinical trial management system market. Shareholders in the clinical trial management system market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the clinical trial management system market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the clinical trial management system market offers information divided into five important segments - mode of delivery, system type, components, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Mode of Delivery

Cloud based clinical trial management system

Web based clinical trial management system

On-premise clinical trial management system

System Type

Enterprise based clinical trial management system

Site based clinical trial management system

Components

Hardware

Services

End User

Pharmaceuticals

Clinical Research Organizations (CROs)

Healthcare Providers

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for clinical trial management systems over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the clinical trial management system market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the clinical trial management system market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the clinical trial management system market are more accurate and reliable.

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Key Regulations
4.3. Recent Product Approvals/Launches
4.4. Key promotional Strategies, By Key Players
4.5. PESTEL Analysis
4.6. Porter's Analysis
4.7. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increase in R&D Spending
- 5.2.2. Product Adoption Rate
- 5.2.3. Recent Product Launched/approved
- 5.2.4. Changes in Regulatory Policies
- 5.2.5. Strategic Collaborations
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Mode of Delivery
- 6.1.2. By System Type
- 6.1.3. By Component
- 6.1.4. By End User
- 6.1.5. By Country
6.2. 2022 Market Scenario

7. Global Clinical Trial Management System Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033

7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, By Mode of Delivery

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis, By Mode of Delivery, 2016-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Delivery, 2023-2033
- 8.3.1. Cloud based clinical trial management system
- 8.3.2. Web based clinical trial management system
- 8.3.3. On-premise clinical trial management system
8.4. Market Attractiveness Analysis By Mode of Delivery

9. Global Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, By System Type

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By System Type, 2016-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By System Type, 2023-2033
- 9.3.1. Enterprise based clinical trial management system
- 9.3.2. Site based clinical trial management system
9.4. Market Attractiveness Analysis By System Type

10. Global Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, By Component

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By Component, 2016-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Component, 2023-2033
- 10.3.1. Hardware
- 10.3.2. Services
10.4. Market Attractiveness Analysis By Component

11. Global Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, By End User

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2016-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023-2033
- 11.3.1. Pharmaceuticals
- 11.3.2. Clinical Research Organizations (CROs)
- 11.3.3. Healthcare Providers
11.4. Market Attractiveness Analysis By End User

12. Global Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033, By Region

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2022
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Region 2023-2033
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. East Asia
- 12.3.5. South Asia
- 12.3.6. Oceania
- 12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13. North America Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 13.3.1. By Country
  - 13.3.1.1. U.S.
  - 13.3.1.2. Canada
- 13.3.2. By Mode of Delivery
- 13.3.3. By System Type
- 13.3.4. By Component
- 13.3.5. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Mode of Delivery
- 13.4.3. By System Type
- 13.4.4. By Component
- 13.4.5. By End User
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Key Players - Intensity Mapping
13.8. Country Level Analysis & Forecast
- 13.8.1. U.S. Clinical Trial Management System Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Mode of Delivery
    - 13.8.1.2.2. By System Type
    - 13.8.1.2.3. By Component
    - 13.8.1.2.4. By End User
- 13.8.2. Canada Clinical Trial Management System Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Mode of Delivery
    - 13.8.2.2.2. By System Type
    - 13.8.2.2.3. By Component
    - 13.8.2.2.4. By End User

14. Latin America Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 14.3.1. By Country
  - 14.3.1.1. Mexico
  - 14.3.1.2. Brazil
  - 14.3.1.3. Argentina
  - 14.3.1.4. Rest of Latin America
- 14.3.2. By Mode of Delivery
- 14.3.3. By System Type
- 14.3.4. By Component
- 14.3.5. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Mode of Delivery
- 14.4.3. By System Type
- 14.4.4. By Component
- 14.4.5. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
- 14.8.1. Mexico Clinical Trial Management System Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Mode of Delivery
    - 14.8.1.2.2. By System Type
    - 14.8.1.2.3. By Component
    - 14.8.1.2.4. By End User
- 14.8.2. Brazil Clinical Trial Management System Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Mode of Delivery
    - 14.8.2.2.2. By System Type
    - 14.8.2.2.3. By Component
    - 14.8.2.2.4. By End User
- 14.8.3. Argentina Clinical Trial Management System Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Mode of Delivery
    - 14.8.3.2.2. By System Type
    - 14.8.3.2.3. By Component
    - 14.8.3.2.4. By End User

15. Europe Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 15.3.1. By Country
  - 15.3.1.1. Germany
  - 15.3.1.2. Italy
  - 15.3.1.3. France
  - 15.3.1.4. U.K.
  - 15.3.1.5. Spain
  - 15.3.1.6. BENELUX
  - 15.3.1.7. Russia
  - 15.3.1.8. Rest of Europe
- 15.3.2. By Mode of Delivery
- 15.3.3. By System Type
- 15.3.4. By Component
- 15.3.5. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Mode of Delivery
- 15.4.3. By System Type
- 15.4.4. By Component
- 15.4.5. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
- 15.8.1. Germany Clinical Trial Management System Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Mode of Delivery
    - 15.8.1.2.2. By System Type
    - 15.8.1.2.3. By Component
    - 15.8.1.2.4. By End User
- 15.8.2. Italy Clinical Trial Management System Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Mode of Delivery
    - 15.8.2.2.2. By System Type
    - 15.8.2.2.3. By Component
    - 15.8.2.2.4. By End User
- 15.8.3. France Clinical Trial Management System Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Mode of Delivery
    - 15.8.3.2.2. By System Type
    - 15.8.3.2.3. By Component
    - 15.8.3.2.4. By End User
- 15.8.4. U.K. Clinical Trial Management System Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.4.2.1. By Mode of Delivery
    - 15.8.4.2.2. By System Type
    - 15.8.4.2.3. By Component
    - 15.8.4.2.4. By End User
- 15.8.5. Spain Clinical Trial Management System Market Analysis
  - 15.8.5.1. Introduction
  - 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.5.2.1. By Mode of Delivery
    - 15.8.5.2.2. By System Type
    - 15.8.5.2.3. By Component
    - 15.8.5.2.4. By End User
- 15.8.6. BENELUX Clinical Trial Management System Market Analysis
  - 15.8.6.1. Introduction
  - 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.6.2.1. By Mode of Delivery
    - 15.8.6.2.2. By System Type
    - 15.8.6.2.3. By Component
    - 15.8.6.2.4. By End User
- 15.8.7. Russia Clinical Trial Management System Market Analysis
  - 15.8.7.1. Introduction
  - 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.7.2.1. By Mode of Delivery
    - 15.8.7.2.2. By System Type
    - 15.8.7.2.3. By Component
    - 15.8.7.2.4. By End User

16. East Asia Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 16.3.1. By Country
  - 16.3.1.1. China
  - 16.3.1.2. Japan
  - 16.3.1.3. South Korea
- 16.3.2. By Mode of Delivery
- 16.3.3. By System Type
- 16.3.4. By Component
- 16.3.5. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Mode of Delivery
- 16.4.3. By System Type
- 16.4.4. By Component
- 16.4.5. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
- 16.8.1. China Clinical Trial Management System Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Mode of Delivery
    - 16.8.1.2.2. By System Type
    - 16.8.1.2.3. By Component
    - 16.8.1.2.4. By End User
- 16.8.2. Japan Clinical Trial Management System Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Mode of Delivery
    - 16.8.2.2.2. By System Type
    - 16.8.2.2.3. By Component
    - 16.8.2.2.4. By End User
- 16.8.3. South Korea Clinical Trial Management System Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Mode of Delivery
    - 16.8.3.2.2. By System Type
    - 16.8.3.2.3. By Component
    - 16.8.3.2.4. By End User

17. South Asia Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 17.3.1. By Country
  - 17.3.1.1. India
  - 17.3.1.2. Indonesia
  - 17.3.1.3. Malaysia
  - 17.3.1.4. Thailand
  - 17.3.1.5. Rest of South Asia
- 17.3.2. By Mode of Delivery
- 17.3.3. By System Type
- 17.3.4. By Component
- 17.3.5. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Mode of Delivery
- 17.4.3. By System Type
- 17.4.4. By Component
- 17.4.5. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
- 17.8.1. India Clinical Trial Management System Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Mode of Delivery
    - 17.8.1.2.2. By System Type
    - 17.8.1.2.3. By Component
    - 17.8.1.2.4. By End User
- 17.8.2. Indonesia Clinical Trial Management System Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Mode of Delivery
    - 17.8.2.2.2. By System Type
    - 17.8.2.2.3. By Component
    - 17.8.2.2.4. By End User
- 17.8.3. Malaysia Clinical Trial Management System Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Mode of Delivery
    - 17.8.3.2.2. By System Type
    - 17.8.3.2.3. By Component
    - 17.8.3.2.4. By End User
- 17.8.4. Thailand Clinical Trial Management System Market Analysis
  - 17.8.4.1. Introduction
  - 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.4.2.1. By Mode of Delivery
    - 17.8.4.2.2. By System Type
    - 17.8.4.2.3. By Component
    - 17.8.4.2.4. By End User

18. Oceania Clinical Trial Management System Market 2016-2022 and Forecast 2023-2033

18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 18.3.1. By Country
  - 18.3.1.1. Australia
  - 18.3.1.2. New Zealand
- 18.3.2. By Mode of Delivery
- 18.3.3. By System Type
- 18.3.4. By Component
- 18.3.5. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Mode of Delivery
- 18.4.3. By System Type
- 18.4.4. By Component
- 18.4.5. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players - Intensity Mapping
18.8. Country Level Analysis & Forecast
- 18.8.1. Australia Clinical Trial Management System Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Mode of Delivery
    - 18.8.1.2.2. By System Type
    - 18.8.1.2.3. By Component
    - 18.8.1.2.4. By End User
- 18.8.2. New Zealand Clinical Trial Management System Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Mode of Delivery
    - 18.8.2.2.2. By System Type
    - 18.8.2.2.3. By Component
    - 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Clinical Trial Management System Market Analysis 2016-2022 and Forecast 2023-2033

19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
19.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 19.3.1. By Country
  - 19.3.1.1. GCC Countries
  - 19.3.1.2. Turkey
  - 19.3.1.3. North Africa
  - 19.3.1.4. South Africa
  - 19.3.1.5. Rest of Middle East and Africa
- 19.3.2. By Mode of Delivery
- 19.3.3. By System Type
- 19.3.4. By Component
- 19.3.5. By End User
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Mode of Delivery
- 19.4.3. By System Type
- 19.4.4. By Component
- 19.4.5. By End User
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Players - Intensity Mapping
19.8. Country Level Analysis & Forecast
- 19.8.1. GCC Countries Clinical Trial Management System Market Analysis
  - 19.8.1.1. Introduction
  - 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.1.2.1. By Mode of Delivery
    - 19.8.1.2.2. By System Type
    - 19.8.1.2.3. By Component
    - 19.8.1.2.4. By End User
- 19.8.2. Turkey Clinical Trial Management System Market Analysis
  - 19.8.2.1. Introduction
  - 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.2.2.1. By Mode of Delivery
    - 19.8.2.2.2. By System Type
    - 19.8.2.2.3. By Component
    - 19.8.2.2.4. By End User
- 19.8.3. South Africa Clinical Trial Management System Market Analysis
  - 19.8.3.1. Introduction
  - 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.3.2.1. By Mode of Delivery
    - 19.8.3.2.2. By System Type
    - 19.8.3.2.3. By Component
    - 19.8.3.2.4. By End User
- 19.8.4. North Africa Clinical Trial Management System Market Analysis
  - 19.8.4.1. Introduction
  - 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.4.2.1. By Mode of Delivery
    - 19.8.4.2.2. By System Type
    - 19.8.4.2.3. By Component
    - 19.8.4.2.4. By End User

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis

21. Competition Analysis

21.1. Competition Dashboard
21.2. Competition Deep Dive
- 21.2.1. Oracle Corporation
  - 21.2.1.1. Overview
  - 21.2.1.2. Product Portfolio
  - 21.2.1.3. Sales Footprint
  - 21.2.1.4. Key Financials
  - 21.2.1.5. SWOT Analysis
  - 21.2.1.6. Strategy Overview
    - 21.2.1.6.1. Marketing Strategy
    - 21.2.1.6.2. Product Strategy
    - 21.2.1.6.3. Channel Strategy
- 21.2.2. Merge Healthcare Incorporated
  - 21.2.2.1. Overview
  - 21.2.2.2. Product Portfolio
  - 21.2.2.3. Sales Footprint
  - 21.2.2.4. Key Financials
  - 21.2.2.5. SWOT Analysis
  - 21.2.2.6. Strategy Overview
    - 21.2.2.6.1. Marketing Strategy
    - 21.2.2.6.2. Product Strategy
    - 21.2.2.6.3. Channel Strategy
- 21.2.3. Medidata Solutions Inc.
  - 21.2.3.1. Overview
  - 21.2.3.2. Product Portfolio
  - 21.2.3.3. Sales Footprint
  - 21.2.3.4. Key Financials
  - 21.2.3.5. SWOT Analysis
  - 21.2.3.6. Strategy Overview
    - 21.2.3.6.1. Marketing Strategy
    - 21.2.3.6.2. Product Strategy
    - 21.2.3.6.3. Channel Strategy
- 21.2.4. PAREXEL International Corporation
  - 21.2.4.1. Overview
  - 21.2.4.2. Product Portfolio
  - 21.2.4.3. Sales Footprint
  - 21.2.4.4. Key Financials
  - 21.2.4.5. SWOT Analysis
  - 21.2.4.6. Strategy Overview
    - 21.2.4.6.1. Marketing Strategy
    - 21.2.4.6.2. Product Strategy
    - 21.2.4.6.3. Channel Strategy
- 21.2.5. BioClinica
  - 21.2.5.1. Overview
  - 21.2.5.2. Product Portfolio
  - 21.2.5.3. Sales Footprint
  - 21.2.5.4. Key Financials
  - 21.2.5.5. SWOT Analysis
  - 21.2.5.6. Strategy Overview
    - 21.2.5.6.1. Marketing Strategy
    - 21.2.5.6.2. Product Strategy
    - 21.2.5.6.3. Channel Strategy
- 21.2.6. MedNet Solutions, Inc.
  - 21.2.6.1. Overview
  - 21.2.6.2. Product Portfolio
  - 21.2.6.3. Sales Footprint
  - 21.2.6.4. Key Financials
  - 21.2.6.5. SWOT Analysis
  - 21.2.6.6. Strategy Overview
    - 21.2.6.6.1. Marketing Strategy
    - 21.2.6.6.2. Product Strategy
    - 21.2.6.6.3. Channel Strategy
- 21.2.7. Bio-Optronics, Inc.
  - 21.2.7.1. Overview
  - 21.2.7.2. Product Portfolio
  - 21.2.7.3. Sales Footprint
  - 21.2.7.4. Key Financials
  - 21.2.7.5. SWOT Analysis
  - 21.2.7.6. Strategy Overview
    - 21.2.7.6.1. Marketing Strategy
    - 21.2.7.6.2. Product Strategy
    - 21.2.7.6.3. Channel Strategy
- 21.2.8. DSG, Inc.
  - 21.2.8.1. Overview
  - 21.2.8.2. Product Portfolio
  - 21.2.8.3. Sales Footprint
  - 21.2.8.4. Key Financials
  - 21.2.8.5. SWOT Analysis
  - 21.2.8.6. Strategy Overview
    - 21.2.8.6.1. Marketing Strategy
    - 21.2.8.6.2. Product Strategy
    - 21.2.8.6.3. Channel Strategy
- 21.2.9. eClinForce, Inc.
  - 21.2.9.1. Overview
  - 21.2.9.2. Product Portfolio
  - 21.2.9.3. Sales Footprint
  - 21.2.9.4. Key Financials
  - 21.2.9.5. SWOT Analysis
  - 21.2.9.6. Strategy Overview
    - 21.2.9.6.1. Marketing Strategy
    - 21.2.9.6.2. Product Strategy
    - 21.2.9.6.3. Channel Strategy
- 21.2.10. Forte Research Systems, Inc.
  - 21.2.10.1. Overview
  - 21.2.10.2. Product Portfolio
  - 21.2.10.3. Sales Footprint
  - 21.2.10.4. Key Financials
  - 21.2.10.5. SWOT Analysis
  - 21.2.10.6. Strategy Overview
    - 21.2.10.6.1. Marketing Strategy
    - 21.2.10.6.2. Product Strategy
    - 21.2.10.6.3. Channel Strategy

臨床試験管理システムの世界市場：標準的な臨床ワークフローへのデジタル技術の統合の発展、医薬品CRO活動の拡大が市場を促進

Growing Integration of Digital Technologies into Standard Clinical Workflows, as well as the Growing Pharmaceutical CRO Activities will propel the Adoption of Clinical Trial Management Systems

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

第4章 主な成功要因

第5章 市場の背景

第6章 COVID-19危機分析

第7章 世界の臨床試験管理システム市場の需要の分析と予測

第8章 世界の臨床試験管理システム市場分析と予測：配信モード別

第9章 世界の臨床試験管理システム市場分析と予測：システムタイプ別

第10章 世界の臨床試験管理システム市場分析と予測：コンポーネント別

第11章 世界の臨床試験管理システム市場分析と予測：エンドユーザー別

第12章 世界の臨床試験管理システム市場分析と予測：地域別

第13章 北米の臨床試験管理システム市場分析と予測

第14章 ラテンアメリカの臨床試験管理システム市場分析と予測

第15章 欧州の臨床試験管理システム市場分析と予測

第16章 東アジアの臨床試験管理システム市場分析と予測

第17章 南アジアの臨床試験管理システム市場分析と予測

第18章 オセアニアの治験管理システムの市場と予測

第19章 中東・アフリカの臨床試験管理システム市場分析と予測

第20章 市場構造分析

第21章 競合分析

第22章 使用される前提条件と頭字語

第23章 調査手法